• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cell Rep . T cell-specific P2RX7 favors lung parenchymal CD4+ T cell accumulation in response to severe lung infections

tetano

Editor, Senior Moderator
Cell Rep


. 2023 Nov 14;42(11):113448.
doi: 10.1016/j.celrep.2023.113448. Online ahead of print. T cell-specific P2RX7 favors lung parenchymal CD4[SUP]+[/SUP] T cell accumulation in response to severe lung infections

Igor Santiago-Carvalho[SUP] 1 [/SUP], Gislane Almeida-Santos[SUP] 2 [/SUP], Bruna Gois Macedo[SUP] 3 [/SUP], Caio Cesar Barbosa-Bomfim[SUP] 2 [/SUP], Fabricio Moreira Almeida[SUP] 4 [/SUP], Marcos Vinícios Pinheiro Cione[SUP] 2 [/SUP], Trupti Vardam-Kaur[SUP] 3 [/SUP], Mia Masuda[SUP] 3 [/SUP], Sarah Van Dijk[SUP] 3 [/SUP], Bruno Marcel Melo[SUP] 5 [/SUP], Rogério Silva do Nascimento[SUP] 2 [/SUP], Rebeka da Conceição Souza[SUP] 4 [/SUP], Alba Lucínia Peixoto-Rangel[SUP] 4 [/SUP], Robson Coutinho-Silva[SUP] 6 [/SUP], Mario Hiroyuki Hirata[SUP] 7 [/SUP], José Carlos Alves-Filho[SUP] 5 [/SUP], José Maria Álvarez[SUP] 2 [/SUP], Elena Lassounskaia[SUP] 4 [/SUP], Henrique Borges da Silva[SUP] 8 [/SUP], Maria Regina D'Império-Lima[SUP] 9 [/SUP]



Affiliations
Free article Abstract

CD4[SUP]+[/SUP] T cells are key components of the immune response during lung infections and can mediate protection against tuberculosis (TB) or influenza. However, CD4[SUP]+[/SUP] T cells can also promote lung pathology during these infections, making it unclear how these cells control such discrepant effects. Using mouse models of hypervirulent TB and influenza, we observe that exaggerated accumulation of parenchymal CD4[SUP]+[/SUP] T cells promotes lung damage. Low numbers of lung CD4[SUP]+[/SUP] T cells, in contrast, are sufficient to protect against hypervirulent TB. In both situations, lung CD4[SUP]+[/SUP] T cell accumulation is mediated by CD4[SUP]+[/SUP] T cell-specific expression of the extracellular ATP (eATP) receptor P2RX7. P2RX7 upregulation in lung CD4[SUP]+[/SUP] T cells promotes expression of the chemokine receptor CXCR3, favoring parenchymal CD4[SUP]+[/SUP] T cell accumulation. Our findings suggest that direct sensing of lung eATP by CD4[SUP]+[/SUP] T cells is critical to induce tissue CD4[SUP]+[/SUP] T cell accumulation and pathology during lung infections.

Keywords: CD4(+) T cell; CP: Immunology; CXCR3; P2RX7; extracellular ATP; influenza; lung; lung damage; tuberculosis.

 
Back
Top Bottom